Old Point Trust & Financial Services N A’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7K Sell
100
-100
-50% -$5.17K ﹤0.01% 275
2026
Q1
$10.2K Hold
200
﹤0.01% 263
2025
Q4
$5.9K Hold
200
﹤0.01% 291
2025
Q3
$5.17K Hold
200
﹤0.01% 285
2025
Q2
$5.52K Hold
200
﹤0.01% 292
2025
Q1
$5.67K Hold
200
﹤0.01% 311
2024
Q4
$8.32K Hold
200
﹤0.01% 282
2024
Q3
$13.4K Hold
200
﹤0.01% 238
2024
Q2
$23.8K Hold
200
0.01% 200
2024
Q1
$21.3K Hold
200
0.01% 211
2023
Q4
$19.9K Buy
+200
New +$16.8K 0.01% 180
2023
Q3
Sell
-200
Closed -$24.3K 199
2023
Q2
$24.3K Buy
+200
New +$26.7K 0.01% 153

Other funds holding MRNA

Old Point Trust & Financial Services N A's MRNA Position: Q2 2026 in Review

Old Point Trust & Financial Services N A reduced its Moderna (MRNA) stake by 50% in Q2 2026, selling an estimated $5.17K and leaving 100 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #275.

Old Point Trust & Financial Services N A first reported a position in MRNA in Q2 2023 and has held it in 12 quarters since. The position peaked at $24.3K in Q2 2023. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Old Point Trust & Financial Services N A held 100 shares of Moderna worth $7K as of Q2 2026.
  • Old Point Trust & Financial Services N A sold 100 Moderna shares in Q2 2026, an estimated $5.17K.
  • Moderna made up ﹤0.01% of Old Point Trust & Financial Services N A's portfolio in Q2 2026, its #275 holding.
  • Old Point Trust & Financial Services N A first reported a position in Moderna in Q2 2023 and has held it in 12 quarters since.
  • Old Point Trust & Financial Services N A's Moderna position peaked at $24.3K in Q2 2023.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Old Point Trust & Financial Services N A's 13F filing for Q2 2026, filed 30 Jul 2026.